Sparsentan Catalog No.:M20766-C The bioavailability of tenatoprazole is

The bioavailability of tenatoprazole is two-fold greater in the (S)-tenatoprazole sodium salt hydrate form as compared to the free form in dogs

ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26

InChi: InChI=1S/C76H154N2O38/c1-80-4-5-82-8-9-84-12-13-86-16-17-88-20-21-90-24-25-92-28-29-94-32-33-96-36-37-98-40-41-100-44-45-102-48-49-104-52-53-106-56-57-108-60-61-110-64-65-112-68-69-114-72-73-116-75-74-115-71-70-113-67-66-111-63-62-109-59-58-107-55-54-105-51-50-103-47-46-101-43-42-99-39-38-97-35-34-95-31-30-93-27-26-91-23-22-89-19-18-87-15-14-85-11-10-83-7-6-81-3-2-76(79)78-77/h2-75

InChi: InChI=1S/C19H18O11/c20-5-11-14(24)16(26)17(27)19(30-11)29-9-2-1-7(22)18-13(9)15(25)12-8(23)3-6(21)4-10(12)28-18/h1-4

Smiles: C[N+](C)(C)[C@@H](CC1=CNC(=S)N1)C([O-])=O

Sparsentan Catalog No.:M20766-C The bioavailability of tenatoprazole isSparsentan (RE 021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0. 8 and 9. 3 nM, respectively. Product information CAS Number: 254740 64 2 Molecular Weight: 592. 75 Formula: C32H40N4O5S Chemical Name: 4' ({2 butyl 4 oxo 1,3 diazaspiro[4. 4]non 1 en 3 yl}methyl) N (4,5 dimethyl 1,2 oxazol 3 yl) 2' (ethoxymethyl) [1,1' biphenyl] 2 sulfonamide Smiles: